SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?


To: Miljenko Zuanic who wrote (7578)12/20/2002 9:00:38 PM
From: NeuroInvestment  Read Replies (1) | Respond to of 52153
 
The crystalline structure patent I referred to was allowed and made public last June, if I recall correctly. It was not in the old Cyanamid patents. The composition of matter patent is in the name of Bernard Beers (now of DOV), owned by Wyeth and licensed to NBIX. The structure patent was filed by Neurocrine.

Regards,

Harry